Polymer Capital Management (HK)’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Polymer Capital Management (HK)'s DFTX Position: Q3 2026 in Review
Polymer Capital Management (HK) increased its Definium Therapeutics (DFTX) stake by 23% in Q3 2026, buying an estimated $421K and bringing the position to 54,100 shares worth $2.06M. The position accounts for 0.2% of the portfolio, ranked #85.
Polymer Capital Management (HK) first reported a position in DFTX in Q1 2024 and has held it in 3 quarters since. The position peaked at $2.07M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Polymer Capital Management (HK) held 54,100 shares of Definium Therapeutics worth $2.06M as of Q3 2026.
- Polymer Capital Management (HK) bought 10,000 Definium Therapeutics shares in Q3 2026, an estimated $421K.
- Definium Therapeutics made up 0.2% of Polymer Capital Management (HK)'s portfolio in Q3 2026, its #85 holding.
- Polymer Capital Management (HK) first reported a position in Definium Therapeutics in Q1 2024 and has held it in 3 quarters since.
- Polymer Capital Management (HK)'s Definium Therapeutics position peaked at $2.07M in Q2 2026.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Polymer Capital Management (HK)'s 13F filing for Q3 2026, filed 13 Nov 2026.